Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
9.83
+0.15 (1.60%)
Mar 6, 2026, 3:24 PM EST - Market open
Kalaris Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Kalaris Therapeutics stock have an average target of 20.67, with a low estimate of 19 and a high estimate of 23. The average target predicts an increase of 110.27% from the current stock price of 9.83.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 23, 2025.
Analyst Ratings
The average analyst rating for Kalaris Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +93.29% | Dec 23, 2025 |
| Citizens | Citizens | Buy Initiates $20 | Buy | Initiates | $20 | +103.46% | Nov 3, 2025 |
| Raymond James | Raymond James | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +133.98% | Sep 3, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 8, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.77
from -10.44
EPS Next Year
-2.53
from -3.77
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.94 | -2.21 | ||||
| Avg | -3.77 | -2.53 | ||||
| Low | -4.40 | -2.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.